Francis Chou - Chou Associates Management 13F Activity & Position Changes (Q2 2017)

According to the SEC 13F filed on Aug 12, 2026, the Chou Associates Management portfolio showed several notable changes in holdings as of quarter-end Jun 30, 2017. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.

During Q2 2017, the filing reported:

New Buys - None reported

Increases - Teva Pharmaceutical Industries

Reductions - Citigroup, Inc., Nokia Corporation Sponsored

Complete Exits - None reported

These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.

Date	Symbol	Name	Type	Change Qty	% Change	Value	Remaining
Q2 2017	C Citigroup, Inc.	Citigroup, Inc.	Sell	-100,000	-24.4%	$20.81K	310,000
Q2 2017	NOK Nokia Corporation Sponsored	Nokia Corporation Sponsored	Sell	-1,500,000	-54.5%	$7.73K	1,250,000
Q2 2017	TEVA Teva Pharmaceutical Industries	Teva Pharmaceutical Industries	Buy	+290,000	+134.9%	$16.84K	505,000